Literature DB >> 15117283

Domain structure of bi-functional selenoprotein P.

Yoshiro Saito1, Noriko Sato, Masaki Hirashima, Gen Takebe, Shigeharu Nagasawa, Kazuhiko Takahashi.   

Abstract

Human selenoprotein P (SeP), a selenium-rich plasma glycoprotein, is presumed to contain ten selenocysteine residues; one of which is located at the 40th residue in the N-terminal region and the remaining nine localized in the C-terminal third part. We have shown that SeP not only catalyses the reduction of phosphatidylcholine hydroperoxide by glutathione [Saito, Hayashi, Tanaka, Watanabe, Suzuki, Saito and Takahashi (1999) J. Biol. Chem. 274, 2866-2871], but also supplies its selenium to proliferating cells [Saito and Takahashi (2002) Eur. J. Biochem. 269, 5746-5751]. Treatment of SeP with plasma kallikrein resulted in a sequential limited proteolysis (Arg-235-Gln-236 and Arg-242-Asp-243). The N-terminal (residues 1-235) and C-terminal (residues 243-361) fragments exhibited enzyme activity and selenium-supply activity respectively. These results confirm that SeP is a bi-functional protein and suggest that the first selenocysteine residue is the active site of the enzyme and the remaining nine residues function as a selenium supplier.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117283      PMCID: PMC1133894          DOI: 10.1042/BJ20040328

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Identification of selenoprotein P fragments as a cell-death inhibitory factor.

Authors:  Masaki Hirashima; Takeshi Naruse; Hiroaki Maeda; Chikateru Nozaki; Yoshiro Saito; Kazuhiko Takahashi
Journal:  Biol Pharm Bull       Date:  2003-06       Impact factor: 2.233

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  HMW and LMW kininogens.

Authors:  H Kato; S Nagasawa; S Iwanaga
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

4.  Efficient selenium transfer from mother to offspring in selenoprotein-P-deficient mice enables dose-dependent rescue of phenotypes associated with selenium deficiency.

Authors:  Ulrich Schweizer; Marten Michaelis; Josef Köhrle; Lutz Schomburg
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

5.  Characterization of mammalian selenoproteomes.

Authors:  Gregory V Kryukov; Sergi Castellano; Sergey V Novoselov; Alexey V Lobanov; Omid Zehtab; Roderic Guigó; Vadim N Gladyshev
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728

6.  Cell death caused by selenium deficiency and protective effect of antioxidants.

Authors:  Yoshiro Saito; Yasukazu Yoshida; Takashi Akazawa; Kazuhiko Takahashi; Etsuo Niki
Journal:  J Biol Chem       Date:  2003-07-29       Impact factor: 5.157

7.  Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.

Authors:  R Mandle; A P Kaplan
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

8.  A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.

Authors:  K Tomokiyo; Y Nakatomi; T Araki; K Teshima; H Nakano; T Nakagaki; S Miyamoto; A Funatsu; S Iwanaga
Journal:  Vox Sang       Date:  2003-11       Impact factor: 2.144

9.  Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein.

Authors:  C G Cochrane; S D Revak; K D Wuepper
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

10.  Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene.

Authors:  Kristina E Hill; Jiadong Zhou; Wendy J McMahan; Amy K Motley; Raymond F Burk
Journal:  J Nutr       Date:  2004-01       Impact factor: 4.798

View more
  31 in total

1.  ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma.

Authors:  Natalie Sampson; Rafal Koziel; Christoph Zenzmaier; Lukas Bubendorf; Eugen Plas; Pidder Jansen-Dürr; Peter Berger
Journal:  Mol Endocrinol       Date:  2011-01-27

2.  Identification and characterization of a selenoprotein family containing a diselenide bond in a redox motif.

Authors:  Valentina A Shchedrina; Sergey V Novoselov; Mikalai Yu Malinouski; Vadim N Gladyshev
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-22       Impact factor: 11.205

3.  Synthetic seleno-glutaredoxin 3 analogues are highly reducing oxidoreductases with enhanced catalytic efficiency.

Authors:  Norman Metanis; Ehud Keinan; Philip E Dawson
Journal:  J Am Chem Soc       Date:  2006-12-27       Impact factor: 15.419

Review 4.  Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease.

Authors:  Sarah P Short; Jennifer M Pilat; Christopher S Williams
Journal:  Free Radic Biol Med       Date:  2018-05-17       Impact factor: 7.376

5.  Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply.

Authors:  Ulrich Schweizer; Florian Streckfuss; Paco Pelt; Bradley A Carlson; Dolph L Hatfield; Josef Köhrle; Lutz Schomburg
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

6.  Sepp1(UF) forms are N-terminal selenoprotein P truncations that have peroxidase activity when coupled with thioredoxin reductase-1.

Authors:  Suguru Kurokawa; Sofi Eriksson; Kristie L Rose; Sen Wu; Amy K Motley; Salisha Hill; Virginia P Winfrey; W Hayes McDonald; Mario R Capecchi; John F Atkins; Elias S J Arnér; Kristina E Hill; Raymond F Burk
Journal:  Free Radic Biol Med       Date:  2014-01-14       Impact factor: 7.376

7.  Selenoprotein P controls oxidative stress in cornea.

Authors:  Akihiro Higuchi; Kazuhiko Takahashi; Masaki Hirashima; Tetsuya Kawakita; Kazuo Tsubota
Journal:  PLoS One       Date:  2010-03-29       Impact factor: 3.240

8.  Metabolomics signature associated with circulating serum selenoprotein P levels.

Authors:  Romina di Giuseppe; Manja Koch; Ute Nöthlings; Gabi Kastenmüller; Anna Artati; Jerzy Adamski; Gunnar Jacobs; Wolfgang Lieb
Journal:  Endocrine       Date:  2018-11-17       Impact factor: 3.633

9.  Selenoprotein S is involved in maintenance and transport of multiprotein complexes.

Authors:  Anton A Turanov; Valentina A Shchedrina; Robert A Everley; Alexei V Lobanov; Sun Hee Yim; Stefano M Marino; Steven P Gygi; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Biochem J       Date:  2014-09-15       Impact factor: 3.857

Review 10.  Selenoproteins in Tumorigenesis and Cancer Progression.

Authors:  Sarah P Short; Christopher S Williams
Journal:  Adv Cancer Res       Date:  2017       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.